Medscape

Prevention of Intravenous Drug Incompatibilities in an Intensive Care Unit

Drug therapy is a complex process with numerous parameters modulating its success and safety. The selection of a drug and the definition of its dosage regimen, which must consider both disease and ...
Medscape

FDA Okays Tenecteplase for Acute Ischemic Stroke

The US Food and Drug Administration (FDA) has approved the thrombolytic tenecteplase (TNKase, Genentech) for treatment of acute ischemic stroke in adults. The drug is administered as a single, ...
ascopubs.org

Toxicity and efficacy of bolus (BOL) versus continuous intravenous (CIV) dosing of doxorubicin (DOX) in soft tissue sarcoma (STS): Post hoc analysis of a prospective randomized ...

Prospective development of a patient reported outcomes (PRO) tool in desmoid tumors: A novel clinical trial endpoint. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This ...
KOMU

LPN regulation changes, scholarships could ease strain on nurses, hospital executive says

JEFFERSON CITY — In Missouri, licensed practical nurses with the appropriate qualifications can now administer most IV push or bolus medications under the direction and supervision of a registered ...
ascopubs.org

Flavopiridol given as a 30-min intravenous (IV) bolus followed by 4-hr continuous IV infusion (CIVI) results in clinical activity and tumor lysis in refractory chronic ...

Interim safety summary of alemtuzumab vs. chlorambucil as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL) This is an ASCO Meeting Abstract from the 2004 ...